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Introduction
Epilepsy is a one of the most common neurological disorders of childhood leading 
to excessive and abnormal neuronal activity in the brain (1). Status epilepticus has 
been defined as a tonic-clonic seizure lasting more than 30 minutes (2). Whilst the 
definition of active epilepsy (meaning a current diagnosis) includes a history of 
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Epilepsy is one of the most common diseases in Iran contributing to an array of 
health problems. In light of this, the aim of the present study is to examine the 
prevalence of epilepsy in Iran through a systematic review and meta-analysis.
Materials & Methods
A systematic search of several databases including PubMed, scientific 
information databases, Google, Google scholar, Elsevier and Scopus was 
conducted in June 2013.  Observational studies were considered for inclusion if 
they were published in Iranian and examined epilepsy prevalence and/or related 
risk factors. Meta-analysis was conducted using a random effect model with the 
DerSimonian/Laird method. Heterogeneity was examined using the Breslow-
Day test and inconsistency using the I2 statistic.
Results
A total of 45 studies were identified from the search strategy. Of these, nine 
published manuscripts with a total of 7,723 participants were included within 
the review. The pooled prevalence of epilepsy in Iran was estimated to be 
around 5% (95% confident interval (CI) 2 to 8). For each region the prevalence 
of epilepsy in central, northern and eastern Iran were 5% (95%CI 2 to 8), 1% 
(95%CI -1 to 3) and 4% (95%CI 3 to 11) respectively. The most common risk 
factors in order of prevalence were somatic diseases 39% (95%CI 15 to 62), 
convulsion 38% (95%CI 11 to 65), mental diseases 36% (95%CI 15 to 95) 
and hereditary development 26% (95%CI 9 to 42). A meta-regression model 
identified a declining trend in the prevalence of epilepsy within Iran for the last 
decade.      
Conclusion
Pooled analyses from the nine included publications in this review estimate the 
prevalence of epilepsy in Iran to be around 5%. Although this result is much 
higher than rates in other countries, a declining trend in prevalence over the past 
decade was also identified.
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more than one convulsion, a recent convulsion within 
last five years and the need to use anti-epileptic drugs 
(3). The outward effects can vary from wild thrashing 
movements (tonic-clonic seizure) to milder forms with a 
brief loss of awareness (absence seizure). Symptoms of 
an epileptic seizure may include loss of consciousness, 
diminishing physical strength as well as changes in 
behavior, temper and mood (4). Diagnosis is typically 
made based simply on the description of the seizure and 
surrounding events and the most common anti-epileptic 
drugs are Carbamazepine, Primidone, Phenytoin, 
Phenobarbital and Valproate (5). Underlying causes of 
epilepsy can include a genetic predisposition, stroke, head 
injury or ingestion of a toxin (6). Optimizing screening 
schedules for children to identify symptoms of epileptic 
seizures is likely to improve morbidity through the use 
of medications and other prevention programs to avoid 
an epileptic attack (6). Yet despite the known benefits of 
these prevention programs, this does not readily occur 
in clinical care due to a lack of consolidated evidence 
reporting on the prevalence of epilepsy in Iran.
In Tanzania, the prevalence of epilepsy was reported to 
be 10.2 cases per thousand people (7), whilst epileptic 
recurrence was reported at 5.59 per thousand in another 
meta-analysis among an Indian population (8). Higher 
incidences of epilepsy have been reported by some 
studies (mean of 68.7 per thousand people) though this 
has been primarily attributed to infectious diseases and 
premature and/or traumatic births. However, in developed 
countries epilepsy prevalence is reported as low as 43.4 
per ten thousands persons (9). According to one study 
in Iran published in 2004, prevalence of epilepsy had 
increased from 2 to 34 per ten thousands persons during 
the period of 1970 to 2000 (9). This study also identified 
that epilepsy increases among people older than 65 years 
of age and among people of Asian descent (9). However, 
the results from this review are now somewhat dated, 
particularly considering that a number of publications 
relating to the prevalence of epilepsy in Iran have been 
produced in recent years. In light of this gap, we aim 
to perform a systematic review and meta-analysis of the 
latest evidence to quantify the prevalence of epilepsy in 
Iran, which will include sub-group analyses based on 
region, age and risk factors. This meta-analysis will also 
be used to validate the results of the existing reviews 
and has the potential to inform the next phase of clinical 
practice and preventive medicine. 
Materials & Methods
Literature Search: Systematic review of several 
databases was conducted in June 2013, with no lower 
limit set for date of publication. Electronic databases 
including PubMed, Scientific Information Databases 
(SID), Google, Google scholar, Elsevier and Scopus 
were searched for articles published in Iranian that 
examined the subject of epilepsy. The search strategy 
included a combination of several key words which 
were entered into the search fields including: 1) epilepsy 
AND prevalence AND Iran, 2) epilepsy 3) seizure AND 
prevalence AND Iran.
Selection of studies and data extraction: Initial study 
screening was performed by two reviewers and all 
potentially relevant studies were screened independently 
by two review authors to assess eligibility for inclusion 
within the review. All observational studies were 
considered for inclusion. The primary outcome of 
interest was the prevalence of epilepsy in Iran, with 
secondary outcomes examining geographical region, 
age and epileptic risk factors. Studies that only reported 
epilepsy management or treatment options were 
excluded. Data extraction of included studies was 
performed independently by two review authors using 
a standardized data extraction template. This included 
author name, title of article, year and location of study, 
sample size, gender, prevalence of epilepsy (separated 
by men and women when reported), age and epilepsy 
risk factors. 
Statistical Analysis: Meta-analysis was performed 
using method of moments with a random effects model 
[reported as Effect Estimates (ES) with a 95% confidence 
interval (CI)] to take into account variances expected 
between the differing study characteristics. Variance 
for each study was calculated using the binomial 
distribution formula. The presence of heterogeneity 
was determined by the DerSimonian and Laird method 
and the Breslow-Day test. The I2 statistic was used to 
examine the difference for between study variability 
due to heterogeneity rather than chance, with a range 
from 0 to 100 percent (values of 25%, 50% and 75% 
are considered to represent low, medium and high 
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observed between results (ES =0.05; 95%CI 0.02 to 
0.08; p= .000; Figure 5). Epilepsy recurrence based on 
age groups are reported in Figure 6, with prevalence 
estimates of 0.05 (95%CI 0.00 to 0.1; p=0.000) and 0.04 
(95CI% 0.01 to 0.08; p= .000) for people less than or 
equal to 20 years (reported across six studies) and over 20 
years of age (reported across three studies) respectively 
(ES 0.05; 95%CI 0.02 to 0.08; p= 0.033).
Discussion 
The present study has found that the overall prevalence 
of epilepsy in Iran is 5%, with estimates of 3% for 
individuals under 20 years of age and 6% for those over 
20 years. However, some papers (10, 11) have reported 
higher rates of epilepsy for people under 20 years with 
one possible explanation being evaluation of populations 
using smaller sample sizes. Results from other studies 
(12, 13, 14, 15) have produced similar findings to our 
results for people aged over 20 years. A similar meta-
analysis in India found epilepsy prevalence to be 5.59 
per 1000 persons (8). However, more data was available 
to assess the outcome for the Indian study with a total 
pooled sample size of 50,000, in comparison to 7,723 
subjects in our study. Based on the available data we can 
thus assume that the rate of epilepsy in Iran appears is 
higher than estimates in India. 
The Nagchvak et al. (2002) study was found to have the 
highest rate of epilepsy (0.1056) in a sample size of 4,361 
(9) and the Kaheni et al. (2010) study had the lowest 
(0.009) in a sample of 2,058 people (15). Of the four 
risk factors known to cause epilepsy, somatic diseases 
were found to be the most likely to cause an epileptic 
episode followed by seizures, psychological disorders 
and genetic predisposition. These risk factors have 
been reported across several studies including Etemadi 
Far et al. (2005), Pashapour et al. (2001), and Rezaeei 
et al. (2000) (10, 12, 16). When considering epilepsy 
prevalence by geographical regions, higher estimates 
were obtained for central, eastern and northern Iran, 
which is similar to findings from other publications (6).
This review has several limitations including the 
presence of substantial heterogeneity (97.9% according 
to the I2 statistic). In an attempt to explore the causes 
of this variance, we considered the rates of epilepsy 
whilst adjusting for risk factors (seizures, genetic 
heterogeneity respectively). A value of 0% indicates no 
observed heterogeneity while 100% indicates significant 
heterogeneity. Significance was set with  = 0.1 for the 
I2 statistic to estimate inconsistency between studies. 
The presence of heterogeneity was further through 
subgroups analysis and meta-regression. Statistical 
analyses were conducted using the Statistical Software 
Package (STATA) version 11.1 for the subgroups of risk 
factors including psychological, somatic and convulsive 
diseases in age ranges of 0-20 and greater than 20 years. 
Results
A total of 45 studies were identified from the literature 
search, 25 of these underwent full text review and 
nine were assessed as meeting all the criteria for 
inclusion within the review (Figure 1). The nine eligible 
publications reported on the prevalence of epilepsy 
in Iran during 2002 and 2010 with a total combined 
sample size of 7,723 (mean 858 subjects per article). All 
included studies employed cross-sectional designs. The 
characteristics of each study are presented in Table 1. 
Due to the presence of significant heterogeneity (I2= 
97.9%), meta-analyses were conducted using the 
random effects model as depicted in Figure 2. The 
overall prevalence of epilepsy observed across the nine 
studies was 0.05 (95%CI 0.02 to 0.08; I2=97.9%; p= 
0.004). Among individual studies Tehran was found to 
have the highest rate of epilepsy (105 per one thousand 
people) compared to Brigand with the lowest (9 per one 
thousand people). The prevalence of recurrent epilepsy 
is shown in Figure 3 with a decreasing trend observed 
from 2002 to 2010.
Table 2 presents percentages of the four risk factors 
found to cause epilepsy across the nine included studies. 
The most dangerous risk factor was identified as somatic 
diseases (39%) whilst hereditary causes were the least 
common (26%). The prevalence of epilepsy between 
men and women was found to be similar between 
genders and across studies. 
Meta-regression provides one possible reason for the 
variability observed across the nine studies, with a larger 
sample size producing higher epilepsy prevalence rates 
(Figure 4). Moreover, epilepsy distribution across the 
five definitive regions in Iran (north, south, west, east 
and central) may also be responsible for the variability 
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predisposition, somatic and psychological diseases), 
age (0-20 and greater than 20 years) and geographical 
region in Iran (north, west, east, south and central). In 
addition, a random effect model was employed within 
all meta-analyses to adjust for the expected differences 
between studies (caused by examination of a diverse 
population across a large geographical region). Another 
limitation relates to a lack of methodological rigor due to 
inclusion of observational studies and as such selection 
bias is inevitable. Moreover, our analysis is limited 
to only those variables reported within the included 
studies, further restricting the strength of this evidence. 
Reporting on epilepsy status (being stable or unstable 
epilepsy) was not reported among studies with results 
reported as an overview of the population, restricting the 
generalizability of findings. None of the included studies 
reported data on medication efficacy and prevalence was 
not reported across all regions of Iran for every study. 
Finally, the data is limited only to published studies and 
those written in Iranian. It is possible that government 
evaluations and other non-published data may have been 
inadvertently excluded.
In conclusion, although epilepsy in Iran was found 
to be much higher than that in other countries, we did 
observe a decline in prevalence over time. Considering 
this finding, improved reporting of current estimates 
are needed to provide more accurate data on epilepsy 
prevalence, which is necessary to determine if the trend 
observed in this study is being maintained.
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Table 2. Prevalence of Risk Factors of Epilepsy in Iran




        I2                     P
Risk Factors
*Seizure 1326438 (65-11)96.10.006
*Mental disease 23617 36 (57-15)960.001
*Somatic disease 34745 39 (62-15)98.30.001
*Heredity 44341 26 (42-9)92.80.002
1*=Including fever, tonic-colonic convulsions and epilepsy
2*=Depression, Syncope, Hysteria, Dementia, Stress, bipolar disorders, sleep
3*= Brain diseases, trauma, surgery, tumor, systemic disease, premature infant
4*= Family history
  
Table 3.  Regional Epilepsy Prevalence and Age Groups in Iran
Risk factorsSubgroupsNo. of studiesSample sizePrevalence  (95% CI )
Heterogeneity
 I2%                  P
Region









Figure 1. Results of the systematic literature searchFig1. Results of the systematic literature search
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Figure 2: Partial and total epilepsy prevalence using the random effects model. Each square 
represents the effect estimates for each individual study. Their confidence interval for 
epilepsy prevalence is reflected by the size of each square proportional to the weight assigned 
to each study within the meta-analysis. The diamond represents the overall pooled results) 
Fig 2. Partial and total epilepsy prevalence using the random effects model. Each square represents the effect estimates 
for each individual study. Their confidence interval for epilepsy prevalence is reflected by the size of each square 
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Figure 3: Decreasing trend of epilepsy prevalence in the period between 2002 and 2010 in 
Iran  
Fig 3. Decreasing trend of epilepsy prevalence in the period between 2002 and 2010 in Iran
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 Fig 4. Presentation of the relationship between sample size and epilepsy prevalence. Each circle 
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Figure 4: Presentation of the relationship between sample size and epile sy prevalence. Each 
circle represents the sample size and as the volume of each circle increases, the sample size is 
increased  
Fig 5. Regional distribution of epilepsy in Iran. Each square represents the effect estimates for each individual study. 
Their confidence interval for epilepsy prevalence is reflected by the size of each square proportional to the weight 
assigned to each study within the meta-analysis. The diamond represents the overall pooled results 
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Figure 5: Regi al distribution of epilepsy in Iran. Each square repres nts the effect 
estimates for each individual study. Their confidence interval for epilepsy prevalence is 
reflected by the size of each square proportional to the weight assigned to each study within 
the meta-analysis. The diamond represents the overall pooled results) 
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Figure 6: Age distribution of epilepsy in Iran. Each square represents the effect estimates 
for each individual study. Their confidence interval for epilepsy prevalence is reflected by the 
size of each square proportional to the weight assigned to each study within the meta-analysis. 
The diamond represents the overall pooled results) 
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